Phytoestrogens as a risk factor for cerebral sinus thrombosis

Cerebrovascular Diseases

Volumn 20, Issue 2, 2005, Pages 137-138

  Guimarães, Joana ^a   Azevedo, Elsa ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE; PHYTOESTROGEN;

ADULT; ARTICLE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; FEMALE; HUMAN; MEDICAL EXAMINATION; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

FEMALE; HUMANS; ISOFLAVONES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PHYTOESTROGENS; SINUS THROMBOSIS, INTRACRANIAL;

EID: 23844500787     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086805     Document Type: Article

References (17)

1. Chase SK, Youngkin EQ: Postmenopausal hormone replacement and cardiovascular disease: incorporating research into practice. J Obstet Gynecol Neonatal Nurs 2004;33:648-656.
2. Posthuma WF, Westendorp RG, Vandenbroucke JP: Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ 1994;308:1268-1269.
3. Grady D, Rubin SM, Petitti DB, et al: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
4. Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
5. Barrett-Connor E, Grady D, Stefanick Ml: The rise and fall of menopausal hormone therapy. Annu Rev Public Health 2005;26:115-140.
6. Van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, Keinan-Boker L, Rimm EB, Grobbee DE: Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 2005;111:465-471.
7. Lindgren R, Berg G, Hammar M, Zuccon E: Hormonal replacement therapy and sexuality in a population of Swedish postmenopausal women. Acta Obstet Gynecol Scand 1993;72:292-297.
8. Amato P, Marcus DM: Review of alternative therapies for treatment of menopausal symptoms. Climacteric 2003;6:278-284.
9. Kuiper GG, Carlsson B, Grandien K, et al: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-870.
10. Zava DT, Dollbaum CM, Blen M: Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Biol Med 1998;217:369-378.
11. Daly E, Vessey MP, Hawkins MM, et al: Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-980.
12. Jick H, Derby LE, Wald Myers M, et al: Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996;348:981-983.
13. Grady D, Wenger NK, Herrington D, et al: Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 2000;132:689-696.
14. Teed HJ, McGrath BP, Smolich JJ, et al: Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol 2000;20:1404-1409.
15. Glazier MG, Bowman MA: A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001;161:1671-1672.
16. Vincent A, Fitzpatrick LA: Soy isoflavones: are they useful in menopause? Mayo Clin Proc 2000;75:1174-1184.
17. Carusi D: Phytoestrogen as hormone replacement therapy: an evidence-based approach. Prim Care Update Ob Gyns 2000;7:253-259.